Effects of statins on low-density-lipoproteins size: a new role in cardiovascular prevention ?

Manfredi Rizzo, Kasper Berneis

Risultato della ricerca: Articlepeer review

2 Citazioni (Scopus)

Abstract

Cardiovascular diseases still represent the first cause of death in most of the industrialized countries. An effective prevention includes the treatment of a series of risk factors: smoking, hypertension, diabetes, obesity and dyslipidemia.1 Statins represent a class of cholesterol-lowering drugs as inhibitors of the hydroxymethylglutaryl-coenzyme A reductase enzyme which catalyzes one of the first steps of the cholesterol metabolic pathway. This class of drugs has been used in a very large number of patients, in both primary and secondary cardiovascular prevention, for its ability to reduce clinical events linked to atherosclerosis, including acute myocardial infarction, unstable angina, coronary revascularization procedures, cardiac death, stroke, symptoms of peripheral arterial disease and total mortality
Lingua originaleEnglish
pagine (da-a)1015-1016
Numero di pagine2
RivistaSouthern Medical Journal
Volume99
Stato di pubblicazionePublished - 2006

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2700???

Fingerprint

Entra nei temi di ricerca di 'Effects of statins on low-density-lipoproteins size: a new role in cardiovascular prevention ?'. Insieme formano una fingerprint unica.

Cita questo